In our study, Fgf13 knockout mice aged 8–12 weeks showed 30–47% SGN loss and elevated ∼40 dB of SPL at 4–32 kHz frequencies in the ABR test, which might provide new perspectives on the molecular mechanisms underlying SGN loss and deafness. This evidence concerns the gene FGF13 and deafness.